Principal Financial Group Inc. Buys 82,765 Shares of Axon Enterprise, Inc $AXON

Principal Financial Group Inc. increased its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 92.2% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 172,566 shares of the biotechnology company’s stock after acquiring an additional 82,765 shares during the quarter. Principal Financial Group Inc.’s holdings in Axon Enterprise were worth $96,742,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in AXON. Rockefeller Capital Management L.P. increased its holdings in Axon Enterprise by 53.2% during the 4th quarter. Rockefeller Capital Management L.P. now owns 11,518 shares of the biotechnology company’s stock worth $6,542,000 after purchasing an additional 4,002 shares during the period. Legal & General Group Plc lifted its holdings in shares of Axon Enterprise by 1.3% in the 4th quarter. Legal & General Group Plc now owns 426,533 shares of the biotechnology company’s stock worth $242,241,000 after buying an additional 5,419 shares during the period. Eurizon Capital SGR S.p.A. purchased a new stake in shares of Axon Enterprise in the 4th quarter worth $13,116,000. Arrowstreet Capital Limited Partnership bought a new position in shares of Axon Enterprise during the 1st quarter worth $15,067,000. Finally, Harel Insurance Investments & Financial Services Ltd. grew its position in shares of Axon Enterprise by 40.7% during the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 15,083 shares of the biotechnology company’s stock worth $6,406,000 after buying an additional 4,360 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

More Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon raised its full-year 2026 revenue-growth outlook to 32%–34%, supported by approximately $15.1 billion in future contracted bookings and strong momentum in connected devices, AI-enabled software and counter-drone offerings. Second-quarter revenue increased 35.3% year over year to $904.4 million and exceeded analyst expectations. Axon Enterprise Is Up 17.8% After Raising 2026 Revenue Outlook
• Positive Sentiment: Northland Securities raised its FY2027 EPS forecast to $6.49 from $5.53. The firm also increased estimates for Q1, Q2, Q3 and Q4 2027, suggesting stronger expected earnings momentum beyond 2026.
• Positive Sentiment: The company’s second-quarter adjusted earnings and revenue surpassed Wall Street expectations, while management highlighted broad demand for Axon’s public-safety technology ecosystem. The 5 Most Interesting Analyst Questions From Axon’s Q2 Earnings Call
• Neutral Sentiment: Northland reduced its FY2026 EPS estimate to $3.12 from $3.26 and lowered its Q4 2026 forecast to $1.29 from $1.55, partly offsetting the more optimistic 2027 outlook.
• Negative Sentiment: Despite strong sales, quarterly net income fell to $29.4 million from $36.1 million a year earlier, and diluted EPS declined to $0.36 from $0.44. Investors remain concerned about margins, elevated costs, debt and Axon’s very high valuation. Should You Buy, Hold or Sell AXON Stock Post Q2 Earnings Release?
• Negative Sentiment: Recent insider selling has added pressure and increased investor caution around the stock’s valuation. Axon Enterprise Trading Down Following Insider Selling

Axon Enterprise Trading Down 0.4%

AXON opened at $612.83 on Friday. The firm has a market cap of $49.78 billion, a price-to-earnings ratio of 254.29, a PEG ratio of 12.56 and a beta of 1.39. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. Axon Enterprise, Inc has a 12 month low of $339.01 and a 12 month high of $794.29. The stock has a fifty day moving average price of $526.06 and a 200-day moving average price of $474.40.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The firm had revenue of $904.39 million during the quarter, compared to analysts’ expectations of $876.42 million. During the same period in the prior year, the business posted $2.12 EPS. The firm’s quarterly revenue was up 35.3% on a year-over-year basis. As a group, equities research analysts anticipate that Axon Enterprise, Inc will post 1.63 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, insider Elizabeth Reid Coughlin sold 1,554 shares of Axon Enterprise stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $485.00, for a total value of $753,690.00. Following the transaction, the insider owned 34,024 shares of the company’s stock, valued at $16,501,640. The trade was a 4.37% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, President Joshua Isner sold 13,000 shares of Axon Enterprise stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $488.45, for a total transaction of $6,349,850.00. Following the completion of the transaction, the president directly owned 169,125 shares in the company, valued at approximately $82,609,106.25. The trade was a 7.14% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 68,989 shares of company stock valued at $36,016,932 in the last three months. 4.20% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on AXON. Royal Bank Of Canada restated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, July 21st. Weiss Ratings reissued a “hold (c-)” rating on shares of Axon Enterprise in a research report on Wednesday, August 5th. Morgan Stanley boosted their price target on shares of Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Barclays upped their price target on shares of Axon Enterprise from $523.00 to $688.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Finally, Zacks Research downgraded shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 10th. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $730.92.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.